Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $2.6 million.

  • Zhengye Biotechnology Holding's Other Non-Current Assets was N/A to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is 178.38% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Other Non-Current Assets stood at $2.6 million for FY2024, which was up 178.38% from $920,331 recorded in FY2023.
  • Zhengye Biotechnology Holding's Other Non-Current Assets' 5-year high stood at $2.6 million during FY2024, with a 5-year trough of $920,331 in FY2023.
  • Over the past 2 years, Zhengye Biotechnology Holding's median Other Non-Current Assets value was $1.7 million (recorded in 2023), while the average stood at $1.7 million.
  • Data for Zhengye Biotechnology Holding's Other Non-Current Assets shows a peak YoY soared of 178.38% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Other Non-Current Assets (Yearly) stood at $920,331 in 2023, then surged by 178.38% to $2.6 million in 2024.